BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15522089)

  • 21. A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system.
    Urbanowski ML; Lykken GL; Yahr TL
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9930-5. PubMed ID: 15985546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type III Secretion System of Pseudomonas aeruginosa Affects Matrix Metalloproteinase 12 (MMP-12) and MMP-13 Expression via Nuclear Factor κB Signaling in Human Carcinoma Epithelial Cells and a Pneumonia Mouse Model.
    Park JW; Kim YJ; Shin IS; Kwon OK; Hong JM; Shin NR; Oh SR; Ha UH; Kim JH; Ahn KS
    J Infect Dis; 2016 Sep; 214(6):962-9. PubMed ID: 27377745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.
    Sullivan AB; Tam KP; Metruccio MM; Evans DJ; Fleiszig SM
    Infect Immun; 2015 Apr; 83(4):1629-40. PubMed ID: 25667266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system.
    Yahr TL; Wolfgang MC
    Mol Microbiol; 2006 Nov; 62(3):631-40. PubMed ID: 16995895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Hauser AR; Kang PJ; Engel JN
    Mol Microbiol; 1998 Feb; 27(4):807-18. PubMed ID: 9515706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa.
    Kuchma SL; Connolly JP; O'Toole GA
    J Bacteriol; 2005 Feb; 187(4):1441-54. PubMed ID: 15687209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocation of ExsE into Chinese hamster ovary cells is required for transcriptional induction of the Pseudomonas aeruginosa type III secretion system.
    Urbanowski ML; Brutinel ED; Yahr TL
    Infect Immun; 2007 Sep; 75(9):4432-9. PubMed ID: 17635873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
    Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV
    J Bacteriol; 2007 Mar; 189(6):2203-9. PubMed ID: 17209027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes.
    Kulasekara HD; Ventre I; Kulasekara BR; Lazdunski A; Filloux A; Lory S
    Mol Microbiol; 2005 Jan; 55(2):368-80. PubMed ID: 15659157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Backbone Interactions Between Transcriptional Activator ExsA and Anti-Activator ExsD Facilitate Regulation of the Type III Secretion System in Pseudomonas aeruginosa.
    Shrestha M; Bernhards RC; Fu Y; Ryan K; Schubot FD
    Sci Rep; 2020 Jun; 10(1):9881. PubMed ID: 32555263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
    Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
    Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis.
    von Götz F; Häussler S; Jordan D; Saravanamuthu SS; Wehmhöner D; Strüssmann A; Lauber J; Attree I; Buer J; Tümmler B; Steinmetz I
    J Bacteriol; 2004 Jun; 186(12):3837-47. PubMed ID: 15175297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers.
    Berry A; Han K; Trouillon J; Robert-Genthon M; Ragno M; Lory S; Attrée I; Elsen S
    J Bacteriol; 2018 Jun; 200(12):. PubMed ID: 29632090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa SoxR does not conform to the archetypal paradigm for SoxR-dependent regulation of the bacterial oxidative stress adaptive response.
    Palma M; Zurita J; Ferreras JA; Worgall S; Larone DH; Shi L; Campagne F; Quadri LE
    Infect Immun; 2005 May; 73(5):2958-66. PubMed ID: 15845502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-activator ExsD forms a 1:1 complex with ExsA to inhibit transcription of type III secretion operons.
    Thibault J; Faudry E; Ebel C; Attree I; Elsen S
    J Biol Chem; 2009 Jun; 284(23):15762-70. PubMed ID: 19369699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.